You are here

Home » Industry » Prescription medicines » Regulatory decisions and notices » Australian Public Assessment Reports for prescription medicines (AusPARs)

AusPAR: Elasomeran

Related information

Australian Public Assessment Report

23 February 2022
AusPAR Details
AusPAR
AusPAR: Elasomeran (pdf, 2 MB)
AusPAR: Elasomeran (docx, 6 MB)
Attachment: Product information for Elasomeran (pdf, 511 KB)
Attachment: Product information for Elasomeran (docx, 878 KB)
Active Ingredient
Elasomeran
Product Name
Spikevax
Sponsor
Moderna Australia Pty Ltd
Submission Number
PM-2021-05269-1-2
Submission Type
Extension of indications
Decision
Approved for provisional registration
AusPAR Date
21 February 2022
Publication Date

23 February 2022